Treatment of placental chronic histiocytic villulitis using an interleukin-1 inhibitor

摘要

The present invention is, in the end, combined with at least one molecule and / or Interleukin-18 (IL-18), which is conventionally prescribed to treat Chi, combined with chronic histiocytosis Interleukin-1 (IL-1), especially IL-1, for prevention or treatment of its adjunctive symptoms α And / or IL-1 β It relates to the use of inhibitors of the.Interleukin 1 (IL-1), especially IL-1 α And / or IL-1 β An inhibitor of interest may be used for the in vitro Chi diagnosis in an object that is suspected to have contracted Chi, or for monitoring therapeutic efficacy for the subject of interest.